Amanote Research
Register
Sign In
Subcutaneous Immunoglobulin for Maintenance Treatment in Chronic Inflammatory Demyelinating Polyneuropathy - A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial: The PATH Study
Muscle and Nerve
- United States
doi 10.1002/mus.25768
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Neuroscience
Neurology
Physiology
Cellular
Date
September 1, 2017
Authors
Unknown
Publisher
Wiley
Related search
Subcutaneous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy – Neurologist, Nursing and Patient Perspectives
European Neurological Review
Neurology
Aripiprazole for the Treatment of Methamphetamine Dependence: A Randomized, Double-Blind, Placebo-Controlled Trial
Addiction
Medicine
Psychiatry
Mental Health
Mesna for Treatment of Hyperhomocysteinemia in Hemodialysis Patients: A Placebo-Controlled, Double-Blind, Randomized Trial
Clinical Journal of the American Society of Nephrology
Epidemiology
Nephrology
Critical Care
Transplantation
Intensive Care Medicine
Chronic Inflammatory Demyelinating Polyneuropathy
Fluoxetine for Depression in Diabetes: A Randomized Double-Blind Placebo-Controlled Trial
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Minocycline as Adjunctive Treatment for Treatment-Resistant Depression: Study Protocol for a Double Blind, Placebo-Controlled, Randomized Trial (MINDEP2)
BMC Psychiatry
Psychiatry
Mental Health
A Randomized, Placebo-Controlled, Double-Blind Trial of Sertraline for Postpartum Depression
Psychopharmacology
Pharmacology
A Phase II, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
A Randomized, Double-Blinded, Placebo-Controlled Multicenter Trial of Etanercept in the Treatment of Alcoholic Hepatitis
Gastroenterology
Hepatology
Gastroenterology
